SCHEMBL6498255

SCHEMBL6498255

CCOC(=O)CCCOc1cc(C)c2nc(C)n(Cc3ccc(-c4ccccc4)cc3OC)c2c1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FAAH O00519 3/20 0.41
PTPN1 P18031 1/20 0.41
GAA P10253 1/20 0.41
PLA2G2A P14555 3/20 0.40
CYSLTR2 Q9NS75 2/20 0.39
CYSLTR1 Q9Y271 2/20 0.39
PPARG P37231 1/20 0.38
PPARD Q03181 1/20 0.38
PPARA Q07869 1/20 0.38
DHFR P00374 1/20 0.37
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
P2RY12 Q9H244 1/20 0.37
AGTR1 P30556 1/20 0.37
AGTR2 P50052 1/20 0.37
TNF P01375 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6491216 0.92 FFAR4 (0.43) PLA2G2APPARGPPARDPPARA
SCHEMBL6492166 0.89 GAA (0.43) FAAHPTPN1GAAPLA2G2ACYSLTR2
SCHEMBL6489475 0.87 HSD17B2 (0.39) PTPN1PLA2G2ACYSLTR2CYSLTR1PDE3B
SCHEMBL6488150 0.84 PLA2G2A (0.42) FAAHPTPN1GAAPLA2G2ACYSLTR2
SCHEMBL6489154 0.82 ALDH1A1 (0.47) FAAHGAAPLA2G2ACYSLTR2CYSLTR1
SCHEMBL6489324 0.82 BCL2 (0.42) PLA2G2APPARDAGTR1AGTR2
SCHEMBL6496755 0.82 PDE3B (0.44) FAAHPLA2G2ACYSLTR2CYSLTR1PDE3B
SCHEMBL6491512 0.81 MCL1 (0.41) PTPN1PLA2G2ACYSLTR2CYSLTR1PDE3B
SCHEMBL6487030 0.80 PDE3B (0.42) FAAHPTPN1PLA2G2ACYSLTR2CYSLTR1
SCHEMBL6489813 0.80 MCL1 (0.43) PLA2G2APPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014812-A1 Benzimidazole compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014812-A1 Benzimidazole compounds SLC5A1, SLC5A2, G6PD FAAH 4636/4885PTPN1 2165/4885GAA 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.